stoxline Quote Chart Rank Option Currency Glossary
  
electroCore, Inc. (ECOR)
5.29  0.45 (9.3%)    11-17 13:22
Open: 4.84
High: 5.395
Volume: 77,529
  
Pre. Close: 4.84
Low: 4.84
Market Cap: 49(M)
Technical analysis
2026-11-17 12:44:43 PM
Short term     
Mid term     
Targets 6-month :  8.44 1-year :  10.51
Resists First :  7.23 Second :  9
Pivot price 7.07
Supports First :  4.36 Second :  3.63
MAs MA(5) :  5.68 MA(20) :  7.16
MA(100) :  8.41 MA(250) :  7.27
MACD MACD :  -0.9 Signal :  -0.7
%K %D K(14,3) :  16.5 D(3) :  17
RSI RSI(14): 34.1
52-week High :  12.69 Low :  4.36
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
[ ECOR ] has closed above bottom band by 14.7%. Bollinger Bands are 55.8% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 1 days. This is a sign that the current trend might continue.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 5.76 - 5.8 5.8 - 5.83
Low: 4.64 - 4.69 4.69 - 4.72
Close: 4.78 - 4.84 4.84 - 4.89
Company Description

electroCore, Inc. is a commercial-phase medical device enterprise whose focus lies in developing and bringing to market a variety of non-invasive vagus nerve stimulation (nVNS) therapies. Currently, the firm is advancing gammaCore, a prescription-only nVNS therapy specifically engineered for adults to acutely treat the discomfort associated with both migraine and episodic cluster headaches. Its flagship offering, the gammaCore Sapphire, is a portable, rechargeable, and refillable device intended for either regular or intermittent use over many years. Established in 2005, its corporate headquarters are situated in Rockaway, New Jersey.

Headline News

Mon, 16 Nov 2026
Director buys 10,000 electroCore (ECOR) shares at a $5.44 average price. - Stock Titan

Mon, 09 Nov 2026
electroCore (ECOR) Upgraded to Buy: Here's What You Should Know - Yahoo Finance

Wed, 04 Nov 2026
Sales rose 12% at electroCore (ECOR), but its cash outlook brings a warning. - Stock Titan

Wed, 04 Nov 2026
electroCore, Inc. (ECOR) Reports Q3 Loss, Misses Revenue Estimates - Yahoo Finance

Thu, 29 Oct 2026
electroCore to Announce Third Quarter September 30, 2026, Financial Results on Wednesday, November 4, 2026 - GlobeNewswire

Thu, 08 Oct 2026
When Can We Expect A Profit From electroCore, Inc. (NASDAQ:ECOR)? - Simply Wall St

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Underperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Underperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Medical - Devices
Shares Out 9 (M)
Shares Float 6 (M)
Held by Insiders 34.1 (%)
Held by Institutions 11.9 (%)
Shares Short 348 (K)
Shares Short P.Month 322 (K)
Stock Financials
EPS -1.37
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) -0.21
Profit Margin -40 %
Operating Margin -29.4 %
Return on Assets (ttm) -55 %
Return on Equity (ttm) 0 %
Qtrly Rev. Growth 28 %
Gross Profit (p.s.) 3.48
Sales Per Share 4
EBITDA (p.s.) -1.48
Qtrly Earnings Growth 0 %
Operating Cash Flow -10 (M)
Levered Free Cash Flow -5 (M)
Stock Valuations
PE Ratio -3.92
PEG Ratio 0
Price to Book value -25.34
Price to Sales 1.32
Price to Cash Flow -5.05
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

Stoxline iOS

Alpha Bridge iOS

OptionCalc iOS

StockChart Android

Stoxline Android

Alpha Bridge Android

OptionCalc Android